Long-term Follow-up of Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101)
NCT04495582 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8
Last updated 2025-01-07
Summary
The study purpose is conducting follow-up surveillance for the incidence of adverse events and efficacy of subjects participated in phase 1 trial to evaluate the safety and tolerability of autologous bone marrow-derived mesenchymal stem cells (CS10BR05) in subjects with Multiple System Atrophy until 60 months from administering investigational product (IP).
Conditions
Sponsors & Collaborators
-
Corestemchemon, Inc.
lead INDUSTRY
Principal Investigators
-
Phil Hyu Lee, MD · Yonsei University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-28
- Primary Completion
- 2024-09-25
- Completion
- 2024-09-25
Countries
- South Korea
Study Locations
More Related Trials
-
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials
NCT05335876 ·Status: RECRUITING ·Phase: PHASE3
-
Mesenchymal Stem Cell Therapy in Multiple System Atrophy
NCT02315027 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS
NCT02017912 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Therapy for Amyotrophic Lateral Sclerosis
NCT01984814 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Effect of Human Adipose Tissue-derived MSCs in Romberg's Disease
NCT01309061 ·Status: COMPLETED ·Phase: NA
-
Neurologic Stem Cell Treatment Study
NCT02795052 ·Status: RECRUITING ·Phase: NA
-
Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral Sclerosis
NCT02881489 ·Status: UNKNOWN ·Phase: PHASE1
-
Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
NCT01730716 ·Status: UNKNOWN ·Phase: PHASE2
-
Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS)
NCT01142856 ·Status: COMPLETED ·Phase: PHASE1
-
Stem Cell Therapy in Limb Girdle Muscular Dystrophy
NCT02050776 ·Status: WITHDRAWN ·Phase: PHASE1
-
The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis
NCT01494480 ·Status: UNKNOWN ·Phase: PHASE2
-
Compassionate Treatment : An Exploratory Clinical Trial to Assess Treatment of Amyotrophic Lateral Sclerosis
NCT02383654 ·Status: COMPLETED ·Phase: PHASE1
-
Repeated Mesenchymal Stem Cell Injections in ALS
NCT04821479 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy
NCT05167721 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Transplantation of Autologous Peripheral Blood Mononuclear Cells for Amyotrophic Lateral Sclerosis
NCT03085706 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients
NCT05824169 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS
NCT05003921 ·Status: SUSPENDED ·Phase: PHASE1
-
An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in ISIS 396443-CS2 (NCT01703988) or ISIS 396443-CS10 (NCT01780246)
NCT02052791 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT01777646 ·Status: COMPLETED ·Phase: PHASE2
-
Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)
NCT03268603 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety/Efficacy Study of 2nd Cycle Treatment After 6 Months of 1st Cycle HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in ALS
NCT03214146 ·Status: UNKNOWN ·Phase: PHASE1
-
Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy
NCT03067831 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS)
NCT01640067 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)
NCT06973629 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis
NCT02917681 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2